推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

… -blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2–negative, …

[HTML] from jcojournal.orgNJ Robert, V Diéras, J Glaspy… - Journal of Clinical …, 2011 - jcojournal.org
Presented in part at the 45th Annual Meeting of the American Society for Clinical Oncology, May
29-June 2, 2009, Orlando, FL, and at the 15th Congress of the European Cancer Organisation
and 34th Congress of the European Society for Medical Oncology Multidisciplinary ...
Cited by 161 - Related articles - All 7 versions

Plasma insulin-like growth factor I, insulin-like growth factor (IGF)-binding protein-3 and mamographic density

C Byrne, GA Colditz, WC Willett… - Cancer …, 2011 - espace.library.uq.edu.au
... Plasma insulin-like growth factor I, insulin-like growth factor (IGF)-binding protein-3 and
mamographic density. ... Title, Plasma insulin-like growth factor I, insulin-like growth factor
(IGF)-binding protein-3 and mamographic density. Journal name, Cancer Research. ...
Cited by 13 - Related articles - Cached - All 3 versions

Connective tissue growth factor antagonizes transforming growth factor-{beta} 1/Smad signalling in renal mesangial cells.

H O'Donovan, F Hickey, D Brazil, D Kavanagh… - 2011 - biochemj.org
The critical involvement of transforming growth factor-β1 (TGF-β1) in diabetic nephropathy
(DN) is well established, however the role of connective tissue growth factor (CTGF) in regulating
the complex interplay of TGF-β1 signalling networks is poorly understood. The purpose of ...
Cached

Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of …

NL Occleston, S O'Kane, HG Laverty… - Wound Repair and …, 2011 - Wiley Online Library
... Discovery and development of avotermin (recombinant human transforming growth
factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring.
Nick L. Occleston PhD,; Sharon O'Kane PhD,; Hugh G. Laverty ...

Regenerative phenotype in mice with a point mutation in transforming growth factor β type I receptor (TGFBR1)

J Liu, K Johnson, J Li, V Piamonte… - Proceedings of the …, 2011 - National Acad Sciences
Jun Liua,1, Kristen Johnsona,1, Jie Lia, Victoria Piamontea, Brian M. Steffya, Mindy H.
Hsieha, Nicholas Nga, Jay Zhanga, John R. Walkera, Sheng Dingb, Ken Muneokac, Xu
Wua, Richard Glynnea,2, and Peter G. Schultz b,2 aGenomics Institute of the Novartis ...

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451